Gln-Trp

    Спецификации
    Код ТН ВЭД 186608

    Как аккредитованный завод Gln-Trp, мы соблюдаем строгие протоколы качества - каждая партия подвергается строгим испытаниям для обеспечения последовательных стандартов эффективности и безопасности.

    Упаковка и хранение
    Упаковка
    Доставка
    Хранение
    Применение Gln-Trp

    In cold-process O/W anti-aging emulsion manufacturing, L-glutaminyl-L-tryptophan is introduced as a post-emulsification active after the bulk temperature falls below 40 °C, because exposure of the tryptophan indole ring to hot aqueous phases above 60 °C increases peptide-bond hydrolysis and photochemical oxidation potential. The peptide is typically pre-blended at 1:9 to 1:19 with 1,3-butylene glycol or pentylene glycol to prevent localized pH shock and to reduce dust formation. At final formulation level, the active Gln-Trp content is maintained between 0.01 wt% and 0.05 wt%; lower levels below 0.005 wt% generally fail to survive process losses, while levels above 0.08 wt% may exceed solubility in high-oil phases and generate visible recrystallization during 4 °C storage. The aqueous phase is prepared with a carbomer or ammonium acryloyldimethyltaurate/VP copolymer thickener hydrated for 90 min at 25–30 °C, adjusted to pH 5.0–5.5 with 18% sodium hydroxide, and combined with an oil phase containing caprylic/capric triglyceride and hydrogenated polyisobutene under a vacuum homogenizer. The rotor-stator tip speed is held at 6 m/s maximum during emulsification; after adding the Gln-Trp pre-blend, shear is reduced to a side-sweep anchor at 200–600 rpm to minimize foam entrapment and peptide denaturation. Batch-to-batch viscosity variance is normally kept below ±15% when pH is maintained between 5.0 and 5.5; pH drift above 5.8 has been associated with increased viscosity loss in acrylate-based gel matrices. Compliance for EU shipments requires a cosmetic product safety report under Regulation (EC) No 1223/2009, Article 10, and label declaration under Article 19(1)(g); US formulations are labeled according to 21 CFR 701.3; Chinese exports require confirmation against the IECIC 2021 inventory under CSAR. Manufacturing is expected to follow ISO 22716:2007 good manufacturing practice for cosmetics. Terminal product types include anti-aging serum, single-dose ampoule, lotion, and gel-cream formats filled into airless packages or amber glass to protect the indole chromophore from UV-induced discoloration.

    What Restricts Gln-Trp Dosing in Periorbital Gel Systems?

    The upper dosing limit for Gln-Trp in periorbital gel systems is constrained by the water-rich, low-buffer-capacity environment and by the need to maintain ocular compatibility in leave-on products applied within 5 mm of the lash line. In these formulas active Gln-Trp is used at 0.005–0.02 wt%, which is lower than facial emulsions because higher peptide concentrations can increase ionic strength and reduce carbomer microgel clarity, yielding a visible haze in clear eye gels. The production sequence typically begins with 0.3–0.6 wt% carbomer or 0.8–1.5 wt% sclerotium gum hydrated for 90–120 min at 25 °C until a uniform mucilage forms. After hydration, the batch is neutralized with 18% sodium hydroxide or arginine to pH 5.2–5.5, and the Gln-Trp stock solution—pre-dispersed in 1,3-butylene glycol at 1:9—is metered into the vortex with a peristaltic pump at 0.3–0.5 L/min per 100 kg batch. High-shear homogenization above 3,000 rpm is deliberately avoided once the peptide is present because rotor-stator agitation can induce foam and shear-thinning hysteresis in the polymer network. Terminal product formats include roll-on eye gel, clear eye serum, eye contour lotion, and hydrogel under-eye patches; the patch matrix is generally coated or impregnated after the gel reaches 25 °C to prevent premature crosslinking. Safety documentation for EU cosmetic use is anchored to Regulation (EC) No 1223/2009, Article 10, and ocular irritation screening is commonly conducted according to OECD TG 492 using a reconstructed human cornea-like epithelium; ISO 22716:2007 controls the manufacturing environment. Formulators should confirm the peptide raw material is free of residual trifluoroacetic acid above the supplier's specified limit because acidic residues can depress pH below 4.5 and destabilize the carbomer gel.

    RegionRegulation/StandardDesignationRequirement in Gln-Trp Formulation Transfer
    European UnionRegulation (EC) No 1223/2009Article 10, Article 19(1)(g)Pre-market safety assessment and INCI label entry as L-glutaminyl-L-tryptophan
    European UnionISO 22716:2007Cosmetic GMPDocumented batch records, raw material quarantine, traceability
    United States21 CFR 701.3Ingredient labelingDeclare peptide using INCI name in descending order of predominance
    ChinaCSARIECIC 2021 listingConfirm ingredient notification status; new cosmetic ingredient filing if needed
    InternationalISO 11930:2019Preservation efficacyChallenge testing for aqueous cosmetic formulations; bacteria/fungi acceptance criteria
    Ocular safetyOECD TG 492Reconstructed corneal epitheliumEye irritation screening for periorbital finished products

    Where a lamellar gel-network barrier cream is specified with 0.01–0.07 wt% active Gln-Trp, the compounding route requires a deliberately low-shear cooling profile, since lamellar bilayers are sensitive to uncontrolled shear after solidification begins between 45 °C and 38 °C. In this process, a high-behenic acid emulsifier system at 4.0–6.0 wt%—typically glyceryl stearate/PEG-100 stearate combined with cetearyl alcohol—is melted with the oil phase at 75–80 °C, while the water phase containing glycerin and a polymeric thickener is heated to 75–78 °C. Emulsification under a vacuum homogenizer proceeds at 2,500–3,500 rpm for 6–10 min, after which the batch is cooled to 38–42 °C before the Gln-Trp pre-blend is added. The peptide pre-blend is prepared at 1:9 in pentylene glycol and introduced into the side-swept anchor zone at 30–50 rpm to minimize lamellar disruption; post-incorporation viscosity typically falls between 40,000 mPa·s and 70,000 mPa·s at 25 °C, with yield stress in the range of 8–15 Pa. Formula constraints include avoidance of polyvalent metal ions above 0.05 wt%, which can compress the lamellar phase and produce oil separation, and avoidance of strong oxidizers such as benzoyl peroxide above 2.5 wt%, which oxidize the tryptophan indole ring. Preservation must satisfy ISO 11930:2019 challenge-test criteria, and nonsterile bulk acceptance usually follows USP <61> and <62> for microbial limits. EU finished goods fall under Regulation (EC) No 1223/2009; manufacturing records are maintained under ISO 22716:2007. Terminal formats include cica balm, barrier-recovery cream, post-peel occlusion balm, and overnight sleeping mask, all in occlusive packaging that limits water vapor loss and UV exposure.

    Fragment Condensation Utility of Gln-Trp in Laboratory-Scale Custom Peptide Synthesis

    During fragment condensation campaigns with L-glutaminyl-L-tryptophan, batch records show that the dipeptide is used at 1.05–1.20 mol equivalents relative to the resin-bound amino acid or solution-phase nucleophile when it is employed as an activated fragment in Fmoc/tBu solid-phase protocols. This stoichiometric range is not a cosmetic addition level but a coupling ratio selected to compensate for activated-ester hydrolysis in the condensation medium. The terminal amino group of Gln-Trp is either left free for subsequent chain extension or protected as an Fmoc derivative; the indole nitrogen of tryptophan is generally left unprotected in routine syntheses, which requires the use of TIS or indole scavengers in the cleavage cocktail. A standard cleavage mixture of 95:2.5:2.5 TFA/TIS/water is used for 2–3 h at 25 °C, followed by precipitation in cold methyl tert-butyl ether at −20 °C. Preparative purification is performed on a C18 reversed-phase HPLC column with a 0.1% TFA acetonitrile gradient, and the collected fraction is lyophilized at −50 °C shelf temperature. Terminal product types include custom research peptides, impurity qualification standards, and low-volume peptide API candidates for early-process development. Quality documentation should include ISO 9001:2015 raw material release, and if the dipeptide is used in a drug substance starting material, development records are aligned with ICH Q11; EU import requires REACH registration confirmation for manufactured chemical substances. Published pilot-scale data for this specific unprotected dipeptide fragment in custom peptide synthesis is limited, so each coupling condition should be verified by resin-loading depletion monitored via UV absorption at 280 nm.

    When Gln-Trp Enters Preserved Aqueous Toner Systems Above 90 wt% Water

    Compounding preserved aqueous toner systems with Gln-Trp at water content above 90 wt% requires cold addition because heating of high-water systems can accelerate deamidation of the glutamine side chain at pH values below 4.0 and above 6.5. The active addition ratio in preserved aqueous toner and mist formats is typically 0.005–0.03 wt%, with the pre-blend dissolved in cold water at 25 °C before introduction into the main tank. The manufacturing sequence uses a stainless-steel mixing vessel equipped with a bottom magnetic mixer or static mixer rather than a rotor-stator, since high-shear aeration in low-viscosity solutions can oxidize the peptide. After dissolving humectant and preservative, the bulk pH is adjusted to 5.0–5.5 with a citrate buffer; the Gln-Trp pre-blend is then metered in and mixed for 20–30 min. The finished solution is passed through a 0.2 μm polyethersulfone membrane filter; nylon membranes are avoided because peptide adsorption reduces assay recovery. A terminal preservation efficacy test under ISO 11930:2019 is required for aqueous leave-on products, and production documentation follows ISO 22716:2007. EU market access requires compliance with Regulation (EC) No 1223/2009, Article 10, and label declaration under Article 19(1)(g). Terminal formats include facial toner, setting mist, essence mist, and sheet mask impregnation fluid, with airless or amber PET packaging preferred to limit UV transmission and oxidative discoloration of the tryptophan indole chromophore.

    Бесплатная цитата

    Конкурентные цены Gln-Trp, которые соответствуют вашему бюджету - гибкие условия и индивидуальные котировки для каждого заказа.

    Для получения образцов, цен или более подробной информации свяжитесь с нами по адресу +8618136850665 или отправить по почте admin@ascent-chem.com.

    Мы ответим вам как можно скорее.

    Телефон: +8618136850665

    Электронная почта: admin@ascent-chem.com

    Запрос

    Получите бесплатную сметуAscent Petrochem Holdings Co., Limited

    Гибкие условия оплаты, конкурентоспособные цены, первоклассное обслуживание — обращайтесь прямо сейчас!

    Сертификация и соответствие требованиям
    Более подробное введение

    Gln-Trp is the synthetic dipeptide formed from L-glutaminyl and L-tryptophanyl residues linked through a standard peptide bond. The free-base molecular formula is C16H20N4O4, with an average molecular weight of 332.36 g/mol and a monoisotopic [M+H]+ mass of 333.16 m/z. Preparative reversed-phase purification frequently uses trifluoroacetate-containing mobile phases, so the product is commonly supplied as the trifluoroacetate salt; the counterion mass adds 114.02 g/mol per equivalent and must be accounted for when reconstitution molarity is calculated. Supplier-specific model codes differentiate salt form, purity tier, and endotoxin control: GT-1001 research-grade TFA salt, GT-1002 cell culture-grade material with reduced endotoxin and low residual TFA, and GT-1003 desalted acetate form. No harmonized ISO model numbering system applies to this product. Specifications are supplier-defined and typically derived from methods aligned with compendial chromatography, water determination, and bacterial endotoxin procedures.

    Parameter Method reference GT-1001 research grade GT-1002 cell culture grade GT-1003 desalted acetate
    Appearance Visual inspection White to off-white lyophilized solid White lyophilized solid White to off-white lyophilized solid
    Purity by HPLC USP <621> / Ph. Eur. 2.2.29 95.0% 98.0% 96.0%
    Identity by LC-MS ESI positive [M+H]+ 333.16 ± 1.0 m/z [M+H]+ 333.16 ± 1.0 m/z [M+H]+ 333.16 ± 1.0 m/z
    Water content USP <921> Method Ic 5.0% 5.0% 5.0%
    Trifluoroacetate content Ion chromatography Report value 0.5% 0.05%
    Residual acetonitrile GC headspace per ICH Q3C(R8) 410 ppm 410 ppm 410 ppm
    Bacterial endotoxin Ph. Eur. 2.6.14 Not controlled 0.5 EU/mg 0.5 EU/mg
    Storage Supplier certificate of analysis -20 °C ± 5 °C under inert gas -20 °C ± 5 °C under inert gas -20 °C ± 5 °C under inert gas

    No harmonized pharmacopeial monograph is assigned specifically to Gln-Trp; the methods listed are compendial references applied to peptide analysis. The absence of a dedicated monograph means certificate-of-analysis parameters should be reviewed against the intended use, particularly where cell culture or analytical reference applications require defined counterion content.

    What Degradation Pathways Constrain Gln-Trp Handling in Aqueous Media?

    The dominant stability constraints for Gln-Trp arise from the glutaminyl side chain and the indole chromophore. Deamidation of the glutaminyl residue proceeds through pH-dependent hydrolysis; under acidic conditions, the side-chain amide can convert to a carboxylic acid with a mass shift of +0.984 Da, while under neutral-to-alkaline conditions, succinimide formation can generate a mixture of α- and β-glutamyl peptides. The tryptophanyl indole ring undergoes photo-oxidation in the presence of dissolved oxygen and light, forming N-formylkynurenine and related ring-opened products. Aqueous stock solutions should therefore be kept at 2–8 °C, protected from light, and used within 24 h unless a stability study demonstrates longer hold times for the specific buffer. Published data for Gln-Trp-specific degradation kinetics is limited; the described pathways are extrapolated from peptide stability literature and should be confirmed by forced degradation studies aligned with ICH Q2(R1) before analytical method transfer.

    Amine-containing buffers may alter the pH of reconstituted TFA salt solutions and should be evaluated for precipitation. Weighing of lyophilized powder above 60% relative humidity is discouraged because the powder is hygroscopic and can absorb moisture rapidly. In production settings, compounding is carried out in a dry nitrogen glovebox or a desiccated enclosure with monitored dew point below -20 °C. These controls limit water uptake that would otherwise accelerate deamidation and reduce weigh accuracy.

    In reversed-phase liquid chromatography, the indole side chain gives Gln-Trp strong retention on C18 columns relative to non-aromatic dipeptides. A representative purity method uses a 150 × 4.6 mm C18 column with 5 µm particles, mobile phase A consisting of 0.1% TFA in water and mobile phase B consisting of 0.1% TFA in acetonitrile, a linear gradient from 5% to 60% B over 20 min, flow rate 1.0 mL/min, column temperature 30 °C, and detection at 214 nm and 280 nm. The ratio of peak areas at 214 nm and 280 nm can be used to screen for co-eluting non-aromatic impurities. System suitability criteria should follow USP <621>, with a tailing factor not exceeding 2.0 for the Gln-Trp peak.

    Lyophilized Cake Characteristics and Residual Solvent Thresholds

    Visual inspection of lyophilized Gln-Trp cakes provides an early indicator of formulation defects. A collapsed cake, melt-back, or discoloration from white to yellow-brown suggests excessive residual moisture, incomplete freezing, or exposure to light and oxygen during drying. Karl Fischer moisture content is controlled at ≤5.0% by USP <921> Method Ic; higher values are associated with increased rates of hydrolytic degradation and handling weight errors. Residual acetonitrile from preparative chromatography is controlled at ≤410 ppm per ICH Q3C(R8). Vial headspace is backfilled with nitrogen or argon, and closures are selected for low moisture vapour transmission. For cell culture-grade material, bacterial endotoxin is controlled at ≤0.5 EU/mg using the limulus amoebocyte lysate test aligned with Ph. Eur. 2.6.14. The lyophilized product should be equilibrated to ambient temperature inside a sealed container before opening to prevent condensation.

    Reconstitution for cell culture and transport experiments is typically performed at 1.0 mg/mL in sterile 10 mM hydrochloric acid or 0.1 M acetic acid, followed by dilution into the target medium. Direct reconstitution in phosphate-buffered saline at neutral pH can result in slow dissolution and is not recommended for concentrated stocks. Solutions are filtered through a 0.22 µm polyethersulfone membrane after reconstitution to remove particulates, but filtration does not remove soluble aggregates. If the material is to be used in a serum-free medium, the final formulation should be checked for visible precipitation over 24 h at 2–8 °C.

    When Gln-Trp Is Evaluated Against Ala-Gln and Free Tryptophan

    This dipeptide occupies a different formulation space from the widely used parenteral nutrition dipeptide alanyl-glutamine. Ala-Gln has a molecular weight of 217.22 g/mol, no aromatic chromophore, and high aqueous solubility; it is typically detected at 214 nm rather than 280 nm. Gln-Trp carries the indole side chain, which enables selective detection by UV absorbance at 280 nm but reduces aqueous solubility and increases retention on reversed-phase columns. Free L-tryptophan has a molecular weight of 204.23 g/mol and is susceptible to medium degradation and oxidation; the dipeptide form is used in some experimental systems to reduce free amino acid accumulation spikes. Published data for Gln-Trp-specific formulation performance is limited, and any substitution of free tryptophan or Ala-Gln in a defined medium requires verification of cellular uptake, osmolality, and final filtration behaviour.

    Compound Molecular weight UV chromophore Typical analytical detection Solubility in aqueous media Primary application context
    Gln-Trp 332.36 g/mol Indole 280 nm RP-HPLC 214/280 nm Salt-form dependent Experimental transport studies and analytical reference
    Ala-Gln 217.22 g/mol None RP-HPLC 214 nm High Parenteral nutrition and media supplement
    Gly-Trp 261.28 g/mol Indole 280 nm RP-HPLC 214/280 nm Moderate Peptide transport model substrate
    Free L-tryptophan 204.23 g/mol Indole 280 nm Amino acid analysis Low to moderate Cell culture media and supplement

    In oligopeptide transport assays, Gln-Trp can serve as a model substrate for proton-coupled oligopeptide transporter-mediated uptake. The glutaminyl residue provides a polar side chain, while the tryptophanyl residue supplies a hydrophobic, UV-detectable chromophore. Cellular uptake studies using intestinal epithelial cell lines require correction for extracellular hydrolysis; the dipeptide can be cleaved by brush-border peptidases, releasing glutamine and tryptophan. Stock solutions for transport assays are prepared in 10 mM MES buffer at pH 6.0 to reduce spontaneous deamidation and are then diluted into transport buffer immediately before use. Inhibitor controls may include excess glycylsarcosine, a non-hydrolysable model substrate for peptide transporters; however, the inhibition profile of Gln-Trp should be established in the specific cell model because published data for this specific configuration is limited.

    For in-house synthesis of Gln-Trp derivatives, Fmoc-Gln(Trt)-OH and H-Trp-O-resin are standard building blocks. Coupling reactions require activation reagents such as HBTU or HATU in the presence of a tertiary amine. The glutamine side-chain trityl protecting group is retained until final cleavage to avoid deamidation; cleavage cocktails containing trifluoroacetic acid remove the trityl group and release the peptide, producing the TFA salt. The tryptophanyl residue is sensitive to alkylating agents and strong oxidizers; cleavage with ethanedithiol or triisopropylsilane as scavengers minimizes indole alkylation. RP-HPLC purification with 0.1% TFA mobile phases is standard for this compound class.

    For analytical reference work, a certificate of analysis should include peptide content by quantitative amino acid analysis following acid hydrolysis in 6 N hydrochloric acid at 110 °C for 24 h, using glutamic acid and tryptophan recovery markers. Tryptophan is labile under acid hydrolysis; alkaline hydrolysis or methanesulfonic acid may be required for accurate recovery. This is particularly relevant when Gln-Trp is used as a standard for peptide quantification in complex matrices.

    ТОП